Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Income from Continuing Operations (2023 - 2025)

Historic Income from Continuing Operations for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $9.6 million.

  • Guardian Pharmacy Services' Income from Continuing Operations rose 10906.57% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.5 million, marking a year-over-year increase of 15787.02%. This contributed to the annual value of -$71.0 million for FY2024, which is 28831.65% down from last year.
  • Guardian Pharmacy Services' Income from Continuing Operations amounted to $9.6 million in Q3 2025, which was up 10906.57% from $8.8 million recorded in Q2 2025.
  • In the past 5 years, Guardian Pharmacy Services' Income from Continuing Operations ranged from a high of $15.8 million in Q2 2024 and a low of -$105.8 million during Q3 2024
  • Over the past 3 years, Guardian Pharmacy Services' median Income from Continuing Operations value was $9.3 million (recorded in 2025), while the average stood at -$4.0 million.
  • In the last 5 years, Guardian Pharmacy Services' Income from Continuing Operations crashed by 141275.2% in 2024 and then skyrocketed by 10906.57% in 2025.
  • Guardian Pharmacy Services' Income from Continuing Operations (Quarter) stood at $14.6 million in 2023, then fell by 18.67% to $11.8 million in 2024, then decreased by 18.98% to $9.6 million in 2025.
  • Its Income from Continuing Operations stands at $9.6 million for Q3 2025, versus $8.8 million for Q2 2025 and $9.3 million for Q1 2025.